GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaSGP Holding SE (XTER:PSG) » Definitions » Net Margin %

PharmaSGP Holding SE (XTER:PSG) Net Margin % : 17.79% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PharmaSGP Holding SE Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. PharmaSGP Holding SE's Net Income for the three months ended in Sep. 2024 was €5.4 Mil. PharmaSGP Holding SE's Revenue for the three months ended in Sep. 2024 was €30.2 Mil. Therefore, PharmaSGP Holding SE's net margin for the quarter that ended in Sep. 2024 was 17.79%.

The historical rank and industry rank for PharmaSGP Holding SE's Net Margin % or its related term are showing as below:

XTER:PSG' s Net Margin % Range Over the Past 10 Years
Min: 13.93   Med: 16.36   Max: 26.7
Current: 16.49


XTER:PSG's Net Margin % is ranked better than
81.61% of 995 companies
in the Drug Manufacturers industry
Industry Median: 3.96 vs XTER:PSG: 16.49

PharmaSGP Holding SE Net Margin % Historical Data

The historical data trend for PharmaSGP Holding SE's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaSGP Holding SE Net Margin % Chart

PharmaSGP Holding SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
26.70 16.82 16.36 13.93 16.22

PharmaSGP Holding SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.43 18.68 15.09 14.62 17.79

Competitive Comparison of PharmaSGP Holding SE's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaSGP Holding SE's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaSGP Holding SE's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaSGP Holding SE's Net Margin % distribution charts can be found below:

* The bar in red indicates where PharmaSGP Holding SE's Net Margin % falls into.



PharmaSGP Holding SE Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

PharmaSGP Holding SE's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=16.397/101.099
=16.22 %

PharmaSGP Holding SE's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=5.373/30.209
=17.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaSGP Holding SE  (XTER:PSG) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


PharmaSGP Holding SE Net Margin % Related Terms

Thank you for viewing the detailed overview of PharmaSGP Holding SE's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaSGP Holding SE Business Description

Traded in Other Exchanges
Address
Lochhamer Schlag 1, Graefelfing, Munich, DEU, 82166
PharmaSGP Holding SE is a pharmaceutical company. The company develops chemical-free, over-the-counter (OTC) drugs and healthcare products. The product portfolio includes RUBAXX for rheumatic pain Restaxil for nerve pain, and Deseo for sexual dysfunction. It has established various consumer brands in important indication areas, such as rheumatic and neuralgic pain or sexual weakness Also, the company offers products for skin aging and vertigo.
Executives
Dr. Clemens Fischer Supervisory Board
Madlena Hohlefelder Supervisory Board

PharmaSGP Holding SE Headlines

No Headlines